About Gujarat Themis Biosyn Ltd
Data last updated: 22 December 2025
Gujarat Themis Biosyn Ltd is a public limited company based in Valsad, Gujarat, India, a subsidiary of Pharmaceutical Business Group(Indipharmaceutical Business Group(India) Limiteda) Limited. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 11 December 1981, the company has been in operation for over 45 years.
Registered with ROC Ahmedabad under CIN U24230GJ1981PLC004878. Listed on BSE: 506879.
Capital: an authorised share capital of ₹25 Cr and a paid-up capital of ₹10.9 Cr. It is led by directors including Hitesh Gajaria and Sachin Patel Dinesh.
Last AGM: 12 September 2025. Financial statements filed for year ended 31 March 2025. Office: 69/C Gidc Industrial Estate Vapi, Valsad, Gujarat, India – 396195.
As per the financials filed for FY 2025, the company reported a revenue of ₹153.23 Cr, a decline of 12% compared to the previous year.
The company has a workforce of approximately 354 employees as per the latest available data. It operates as a subsidiary of Pharmaceutical Business Group(Indipharmaceutical Business Group(India) Limiteda) Limited.
The company is associated with 1 brand - Gujarat Themis Biosyn. As per MCA filings, the company has open charges of ₹132.18 Cr and satisfied charges of ₹48.84 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website gtbl.in.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered Address69/C Gidc Industrial Estate Vapi, Valsad, Gujarat, India – 396195
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd has one previous CIN (Corporate Identification Number): U24230GJ1981PLC004878. The current CIN is L24230GJ1981PLC004878, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24230GJ1981PLC004878 | Current |
| U24230GJ1981PLC004878 | Previous |
Associated Brands with Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd operates one associated brand: Gujarat Themis Biosyn. These brands represent Gujarat Themis Biosyn Ltd's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Application development services are provided from Vapi, India. | gtbl.in |
Competitors & Alternatives of Gujarat Themis Biosyn Ltd
Brands and companies operating in the same space as Gujarat Themis Biosyn Ltd include Laurus Labs, Symbiotec, Sterling Pharma Solutions and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Laurus Labs
|
Pharmaceutical and biotechnology company | Hyderabad, India, India | 2005 |
Symbiotec
|
Non-sterile steroid hormone-based APIs and intermediates are manufactured. | Indore, India, India | 2002 |
Sterling Pharma Solutions
|
Contract development, manufacturing, and analytical services for APIs are offered. | Dudley, United Kingdom, United Kingdom | 2016 |
Provepharm Life Solutions
|
APIs and drug products are developed and valorized in pharmaceuticals. | Marseille, France, France | 1998 |
Apicore
|
APIs are manufactured and custom synthesis services are provided. | Somerset, United States, United States | 2004 |
SeQuent
|
APIs are developed and manufactured for therapeutic areas. | Bengaluru, India, India | 2002 |
Jubilant Pharma
|
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | Noida, India, India | 1978 |
Bellen Chemistry
|
APIs and intermediates are researched and manufactured, specializing in heterocycles. | Beijing, China, China | 2007 |
Business Activity of Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd is audited by GMJ & Co. (ICAI peer reviewed, certificate valid till 2027-03-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| GMJ & Co. (ICAI peer reviewed, certificate valid till 2027-03-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd is currently managed by 10 directors, with 33 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Hitesh Gajaria
Also directs:
Parag Parikh Financial Advisory Services Limited
|
Director | 14 May 2024 | 2 Years 1 Months | Current |
|
Sachin Patel Dinesh
Also directs:
Themis Medicare Limited, Dr. Themis Private Limited, Richter Themis Medicare (India) Private Limited and 5 more
|
Managing Director | 25 Oct 2008 | 17 Years 8 Months | Current |
|
Dinesh Shantilal Patel
Also directs:
Themis Medicare Limited, Dr. Themis Private Limited, Richter Themis Medicare (India) Private Limited and 4 more
|
Director | 25 May 1992 | 34 Years 1 Months | Current |
|
Nihar Parikh Ajay
Also directs:
Gift Trunk Llp, Vyox Labs Private Limited, Tejal Merchantile Private Limited and 2 more
|
Director | 01 Aug 2025 | 0 Years 11 Months | Current |
| Rajneesh Kedarnath Anand | Additional Director | 10 Nov 2025 | 0 Years 7 Months | Current |
| Kumarapuram Gopalakrishnan Ananthakrishnan | Director | 26 Jul 2024 | 1 Years 11 Months | Current |
Financials of Gujarat Themis Biosyn Ltd FY 2026 filings available
Gujarat Themis Biosyn Ltd reported revenue of ₹165.82 Cr (up 9.96% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Revenue from Operations | ₹165.82 Cr | ₹150.8 Cr |
| Other Income | ₹2.43 Cr | ₹2.43 Cr |
| Total Income | ₹168.25 Cr | ₹153.23 Cr |
| Cost of Materials Consumed | ₹30.43 Cr | ₹25.78 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 |
| Changes in Inventories | -₹9.03 Cr | -₹1.27 Cr |
| Employee Benefit Expense | ₹16.51 Cr | ₹12.64 Cr |
| Finance Costs | ₹2.95 Cr | ₹36.4 Lakh |
| Depreciation & Amortisation | ₹12.92 Cr | ₹5.37 Cr |
| Other Expenses | ₹52.38 Cr | ₹44.81 Cr |
| Total Expenses | ₹106.16 Cr | ₹87.69 Cr |
| Profit Before Exceptional Items & Tax | ₹62.09 Cr | ₹65.54 Cr |
| Exceptional Items | ₹0 | ₹0 |
| Profit Before Tax | ₹62.09 Cr | ₹65.54 Cr |
| Total Tax Expense | ₹15.41 Cr | ₹16.77 Cr |
| Net Profit | ₹46.68 Cr | ₹48.77 Cr |
| Other Comprehensive Income | ₹50,000 | ₹5.1 Lakh |
| Total Comprehensive Income | ₹46.69 Cr | ₹48.82 Cr |
| EBITDA (computed) | ₹77.96 Cr | ₹71.28 Cr |
| Basic EPS | ₹0.00 | ₹4.48 |
| Diluted EPS | ₹0.00 | ₹4.48 |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Total Assets | ₹503.43 Cr | ₹301.31 Cr |
| Non-current Assets | ₹414.64 Cr | ₹249.34 Cr |
| Current Assets | ₹88.78 Cr | ₹51.97 Cr |
| Property, Plant & Equipment | ₹286.92 Cr | ₹40.58 Cr |
| Inventories | ₹15.42 Cr | ₹5.05 Cr |
| Trade Receivables | ₹60.92 Cr | ₹31.24 Cr |
| Cash & Equivalents | ₹3.12 Cr | ₹11.69 Cr |
| Equity (Net Worth) | ₹287.76 Cr | ₹248.38 Cr |
| Equity Share Capital | ₹10.9 Cr | ₹10.9 Cr |
| Borrowings (Non-current) | ₹128.06 Cr | ₹29.64 Cr |
| Borrowings (Current) | ₹31.8 Cr | ₹25.39 Lakh |
| Total Debt (computed) | ₹159.87 Cr | ₹29.89 Cr |
| Current Liabilities | ₹79.16 Cr | ₹20.56 Cr |
| Total Liabilities | ₹215.67 Cr | ₹52.93 Cr |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Operating Cash Flow | ₹48.78 Cr | ₹91.03 Cr |
| Investing Cash Flow | -₹172.28 Cr | -₹111.82 Cr |
| Financing Cash Flow | ₹114.93 Cr | ₹26.01 Cr |
| Capital Expenditure | ₹172.53 Cr | ₹116.15 Cr |
| Free Cash Flow (computed) | -₹123.76 Cr | -₹25.12 Cr |
| Dividends Paid | ₹7.3 Cr | ₹1.82 Cr |
| Net Change in Cash | -₹8.57 Cr | ₹5.22 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 |
|---|---|---|---|---|---|
| Revenue from Operations | ₹44.23 Cr | ₹43.37 Cr | ₹42.35 Cr | ₹35.87 Cr | ₹37.74 Cr |
| Other Income | ₹92.11 Lakh | ₹41.62 Lakh | ₹81.63 Lakh | ₹27.44 Lakh | ₹1.35 Cr |
| Total Income | ₹45.15 Cr | ₹43.78 Cr | ₹43.17 Cr | ₹36.15 Cr | ₹39.08 Cr |
| Cost of Materials Consumed | ₹10.05 Cr | ₹6.62 Cr | ₹6.92 Cr | ₹6.83 Cr | ₹6.85 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | -₹6.5 Cr | -₹79.85 Lakh | -₹1.53 Cr | -₹19.88 Lakh | -₹62.58 Lakh |
| Employee Benefit Expense | ₹3.79 Cr | ₹4.76 Cr | ₹4.85 Cr | ₹3.11 Cr | ₹3.14 Cr |
| Finance Costs | ₹1.91 Cr | ₹96.04 Lakh | ₹4.04 Lakh | ₹4.21 Lakh | ₹7.14 Lakh |
| Depreciation & Amortisation | ₹4.04 Cr | ₹3.89 Cr | ₹2.96 Cr | ₹2.03 Cr | ₹1.23 Cr |
| Other Expenses | ₹17.52 Cr | ₹11.48 Cr | ₹11.16 Cr | ₹12.21 Cr | ₹12.33 Cr |
| Total Expenses | ₹30.82 Cr | ₹26.91 Cr | ₹24.4 Cr | ₹24.03 Cr | ₹23 Cr |
| Profit Before Exceptional Items & Tax | ₹14.34 Cr | ₹16.87 Cr | ₹18.76 Cr | ₹12.12 Cr | ₹16.09 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹14.34 Cr | ₹16.87 Cr | ₹18.76 Cr | ₹12.12 Cr | ₹16.09 Cr |
| Total Tax Expense | ₹3.45 Cr | ₹4.41 Cr | ₹4.5 Cr | ₹3.06 Cr | ₹4.09 Cr |
| Net Profit | ₹10.89 Cr | ₹12.46 Cr | ₹14.27 Cr | ₹9.06 Cr | ₹12 Cr |
| Other Comprehensive Income | ₹42,000 | ₹2.46 Lakh | ₹1.27 Lakh | ₹1.27 Lakh | ₹5.81 Lakh |
| Total Comprehensive Income | ₹10.9 Cr | ₹12.49 Cr | ₹14.28 Cr | ₹9.07 Cr | ₹12.06 Cr |
| EBITDA (computed) | ₹20.28 Cr | ₹21.72 Cr | ₹21.76 Cr | ₹14.2 Cr | ₹17.39 Cr |
| Basic EPS | ₹0.00 | ₹1.14 | ₹1.31 | ₹0.83 | ₹1.10 |
| Diluted EPS | ₹0.00 | ₹1.14 | ₹1.31 | ₹0.83 | ₹1.10 |
Board & Governance of Gujarat Themis Biosyn Ltd
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Gujarat Themis Biosyn Ltd has 7 directors - 4 independent and 1 executive. The board is chaired by Dinesh Shantilal Patel.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Dinesh Shantilal Patel | Non-Executive - Non Independent Director · Chairperson | 1992-05-25 | 2 |
| Sachin Dinesh Patel | Executive Director · MD | 2025-07-01 | 2 |
| Kirandeep Madan | Non-Executive - Independent Director | 2021-05-01 | 1 |
| Hitesh Dharmasinh Gajaria | Non-Executive - Independent Director | 2024-05-14 | 1 |
| K.G. Anathakrishnan | Non-Executive - Independent Director | 2024-07-26 | 3 |
| Nihar Ajay Parikh | Non-Executive - Independent Director | 2025-08-01 | 1 |
| Rajneesh Kedarnath Anand | Non-Executive - Non Independent Director | 2025-11-10 | 2 |
| Committee | Members |
|---|---|
| Audit Committee | Hitesh Dharmasinh Gajaria (Chairperson), Sachin Dinesh Patel, K.G. Anathakrishnan, Nihar Ajay Parikh |
| Nomination and remuneration committee | Hitesh Dharmasinh Gajaria (Chairperson), Dinesh Shantilal Patel, Nihar Ajay Parikh |
| Stakeholders Relationship Committee | Dinesh Shantilal Patel (Chairperson), Sachin Dinesh Patel, Nihar Ajay Parikh, Rajneesh Kedarnath Anand |
| Risk Management Committee | Sachin Dinesh Patel (Chairperson), Rajneesh Kedarnath Anand, Nihar Ajay Parikh |
| Corporate Social Responsibility Committee | Dinesh Shantilal Patel (Chairperson), Sachin Dinesh Patel, Nihar Ajay Parikh, Rajneesh Kedarnath Anand |
Charges & Borrowings of Gujarat Themis Biosyn Ltd
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Sep 2025 | Others | ₹50 Cr | Open |
| 22 Nov 2024 | Others | ₹80 Cr | Open |
| 17 Jun 2024 | Others | ₹1.43 Cr | Open |
| 19 Oct 2000 | The Vysya Bank Ltd. | ₹75 Lakh | Open |
| 11 Apr 2008 | Union Bank of India | ₹2 Cr | Satisfied |
Total charge records: 16 View all charges
Employees and EPFO Compliance at Gujarat Themis Biosyn Ltd
View historical data on people associated with Gujarat Themis Biosyn Ltd, including employment history and EPFO contributions.
Employee Count & EPFO Data of Gujarat Themis Biosyn Ltd
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Gujarat Themis Biosyn Ltd
GSTIN & GST Filing Data of Gujarat Themis Biosyn Ltd
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Gujarat Themis Biosyn Ltd
Credit Ratings, Legal Cases & Regulatory Alerts of Gujarat Themis Biosyn Ltd
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Gujarat Themis Biosyn Ltd
MSME Payment Delays by Gujarat Themis Biosyn Ltd
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Gujarat Themis Biosyn Ltd
Subsidiaries & Group Companies of Gujarat Themis Biosyn Ltd
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Gujarat Themis Biosyn Ltd with ownership details.
MCA Filings & Documents of Gujarat Themis Biosyn Ltd
MCA Filings & Documents of Gujarat Themis Biosyn Ltd
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Gujarat Themis Biosyn Ltd
Recent News on Gujarat Themis Biosyn Ltd
Frequently Asked Questions about Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd is an active public limited company in the pharma sector based in Valsad, Gujarat, India. It was incorporated on 11 December 1981 (45+ years old) and is registered under CIN L24230GJ1981PLC004878. Listed on BSE: 506879. The company has 354 employees.
Gujarat Themis Biosyn Ltd reported revenue of ₹153.23 Cr for FY 2025 (down 12.00% YoY).
The current directors of Gujarat Themis Biosyn Ltd are:
- Hitesh Gajaria
- Sachin Patel Dinesh
- Dinesh Shantilal Patel
- Nihar Parikh Ajay
- Mr Tapas Bhudebendranath Guhathakurata
- Rajneesh Kedarnath Anand
- Kumarapuram Gopalakrishnan Ananthakrishnan
- Kirandeep Kaur Madan
- Bhavik Kamlesh Shah
- Vineet Ganesh Gawankar
The primary industry of Gujarat Themis Biosyn Ltd is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Yes. Gujarat Themis Biosyn Ltd is listed on BSE with code 506879.
Gujarat Themis Biosyn Ltd can be reached at the registered office: 69C Gidc Industrial Estate Vapi, Valsad, Gujarat, India – 396195, or through the website gtbl.in.